In The Media

Related Articles

'Schwarzenegger' tumor mutation more difficult to treat

April 19, 2016 source: UPI

Many Breast Cancer Patients May Not Need Chemo: Study

April 19, 2016 source: US News & World Report

Agendia's MammaPrint First and Only Genomic Assay to Receive Level 1A Clinical Utility Evidence for Chemotherapy Benefit in Early Breast Cancer Patients

April 18, 2016 source: Business Wire

Evidence show new drug combination may improve outcomes for women with advanced breast cancer

April 18, 2016 source: Medical Xpress

Despite The Glitz, Sean Parker's Cancer Institute Could Be Something Special

April 17, 2016 source: Forbes

Six important updates for BRCA mutation carriers

April 15, 2016 source: HemOnc Today

Nine Out of Ten Mesothelioma Patients Respond to New Immunotherapy Treatment

April 15, 2016 source: Surviving Mesothelioma

Q&A: What can $250 million achieve? Chief of new cancer immunotherapy institute explains

April 15, 2016 source: Science Magazine

MINDACT Trial Findings on Agendia's MammaPrint to be presented during AACR Annual Meeting 2016

April 14, 2016 source: Business Wire

A billionaire's quest to stop cancer

April 14, 2016 source: The Gadsden Times